Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Bernhard Hemmer, Yael Hacohen et al.|The Lancet Neurology|2021Cited by 518
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaXavier Montalbán, Heinz Wiendl, Christine Lebrun‐Frénay et al.|The Lancet Neurology|2025Cited by 314
Clinical Relevance of Brain Volume Measures in Multiple SclerosisNicola De Stefano, Bernd C. Kieseier, Laura Airas et al.|CNS Drugs|2014Cited by 293
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imagingOlga Ciccarelli, David H. Miller, Frederik Barkhof et al.|The Lancet Neurology|2014Cited by 239
Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET EvaluationVito A. G. Ricigliano, Bruno Stankoff, Emanuele Morena et al.|Radiology|2021Cited by 196